We have been advocating that the diversity in genomics research is an issue since Mawi DNA’s inception in 2014. Interestingly, in late 2018 and now 2019 several publications came out to describe this issue in greater details. Unfortunately, such gap of genetic data hinders progress in understanding the global picture of human health and in particular personalized and precision medicine including the pharmacogenomics of how our bodies react to different drugs.
Spit and/or saliva collection might have been an acceptable alternative to getting gDNA from blood sample. But now it is becoming obvious that its use has many limitations:
iSWAB checks all of these requirements and more, making it a true universal sample collection technology!
Swabs are known to be a universal sample collection tool but lacked gDNA quantity and quality. Using it with iSWAB resolves this issue and thus making accessibility of samples from across the globe regardless of age, medical condition or level of education. iSWAB is bringing diversity back to genetic and multi-OMICS research.
Article Sources:
https://www.statnews.com/2019/03/06/lack-diversity-hinders-genetic-studies/
https://www.sciencedaily.com/releases/2019/06/190619142605.htm
https://academic.oup.com/bioscience/article/69/8/684/5522596
https://blogs.scientificamerican.com/voices/we-need-more-diversity-in-our-genomic-databases/
Mawi DNA Partners with Tempus AI and Tally Health™ to…...
October 7, 2024 – Customers frequently ask what swabs are compatible with our iSWAB® non-invasive sample collection technology. Although most swab types can be used with our system, incl...
READ MORESolena Ag and Mawi DNA Partner to Revolutionize Soil Health…...
January 4, 2024 – Solena Ag, a leader in soil health insights for sustainable agriculture, and Mawi DNA Technologies (Mawi DNA), a pioneer in high-integrity sample collection and storage, today anno...
READ MOREiSWAB®-DNA Is in a League of Its Own Among Non-Invasive…...
Key Highlights: